Home › Funds › Octagon Capital Advisors LP › COGT
Octagon Capital Advisors LP position in COGT
COGENT BIOSCIENCES INC · Health Care
Octagon Capital Advisors LP reported holding 2,350,000 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$75.2M, representing 10.02% of its reported portfolio and ranking #4 among its reported holdings. Octagon Capital Advisors LP has disclosed COGT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Octagon Capital Advisors LP's COGT position evolved
Octagon Capital Advisors LP first disclosed a stake in COGT in Q3 2024 at 1,305,000 shares (US$14.1M). The position peaked in Q2 2026 at 2,350,000 shares, worth US$90.9M. Across 9 filings, Octagon Capital Advisors LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 2,350,000 shares valued at US$75.2M. Notable position changes include a 112% increase in Q4 2024 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 1.30M | $14.09M | New |
| Q4 2024 | 2.76M | $21.55M | Add |
| Q1 2025 | 2.76M | $16.55M | Hold |
| Q2 2025 | 2.76M | $19.84M | Hold |
| Q3 2025 | 2.87M | $41.27M | Add |
| Q4 2025 | 2.35M | $83.47M | Reduce |
| Q1 2026 | 2.35M | $90.45M | Hold |
| Q2 2026 | 2.35M | $90.94M | Hold |
| Q3 2026 | 2.35M | $75.25M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COGT and 13F data
COGT (COGENT BIOSCIENCES INC) is a Health Care company. 50 other funds we track also report a position in COGT — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$190.7M), Fairmount Funds Management LLC (US$176.2M), Kynam Capital Management, LP (US$121.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COGT
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.96M sh · $190.74M · Q3 2026
- Fairmount Funds Management LLC 5.50M sh · $176.22M · Q3 2026
- Kynam Capital Management, LP 3.79M sh · $121.43M · Q3 2026
- TCG Crossover Management, LLC 2.50M sh · $80.05M · Q3 2026
- Deep Track Capital, LP 2.50M sh · $80.05M · Q3 2026
- RTW INVESTMENTS, LP 2.31M sh · $73.93M · Q3 2026
- ORBIMED ADVISORS LLC 2.00M sh · $64.16M · Q3 2026
- Venrock Adviser, LLC 1.64M sh · $52.58M · Q3 2026
- EMERALD ADVISERS, LLC 1.61M sh · $51.67M · Q3 2026
- Siren, L.L.C. 1.61M sh · $51.53M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.57M sh · $50.42M · Q3 2026
- Commodore Capital LP 1.26M sh · $40.51M · Q3 2026
More on Octagon Capital Advisors LP
FAQ
How long has Octagon Capital Advisors LP held COGT?
Octagon Capital Advisors LP has disclosed COGT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Octagon Capital Advisors LP's current position in COGT?
As of Q3 2026, Octagon Capital Advisors LP holds 2.35M shares of COGT (COGENT BIOSCIENCES INC), valued at $75.25M, representing 10.02% of its reported portfolio and ranking #4.
Has Octagon Capital Advisors LP been buying or selling COGT?
In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP held unchanged its position in COGT. The position peaked in Q2 2026 at 2.35M shares.
Which other funds hold COGT?
Other major institutional holders of COGT include DEERFIELD MANAGEMENT COMPANY, L.P., Fairmount Funds Management LLC, Kynam Capital Management, LP, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.